vs
GE医疗（CCRN）与PROCORE TECHNOLOGIES, INC.（PCOR）财务数据对比。点击上方公司名可切换其他公司
PROCORE TECHNOLOGIES, INC.的季度营收约是GE医疗的1.5倍（$359.3M vs $236.8M），PROCORE TECHNOLOGIES, INC.净利率更高（-2.5% vs -35.0%，领先32.5%），PROCORE TECHNOLOGIES, INC.同比增速更快（15.7% vs -23.6%），过去两年PROCORE TECHNOLOGIES, INC.的营收复合增速更高（12.4% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
Procore Technologies是2002年成立的美国建筑管理软件即服务（SaaS）企业，总部位于加利福尼亚州卡平特里亚。公司打造的全球平台可连接建筑行业从业者，支持搭建简化工作流，统一展现建筑项目信息，覆盖任务追踪、项目流程管理、日程排期等核心功能。
CCRN vs PCOR — 直观对比
营收规模更大
PCOR
是对方的1.5倍
$236.8M
营收增速更快
PCOR
高出39.3%
-23.6%
净利率更高
PCOR
高出32.5%
-35.0%
两年增速更快
PCOR
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $359.3M |
| 净利润 | $-82.9M | $-9.1M |
| 毛利率 | — | 80.1% |
| 营业利润率 | -30.2% | 15.5% |
| 净利率 | -35.0% | -2.5% |
| 营收同比 | -23.6% | 15.7% |
| 净利润同比 | -2109.7% | 72.4% |
| 每股收益（稀释后） | $-2.56 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNPCOR
| Q1 26 | — | $359.3M | ||
| Q4 25 | $236.8M | $349.1M | ||
| Q3 25 | $250.1M | $338.9M | ||
| Q2 25 | $274.1M | $323.9M | ||
| Q1 25 | $293.4M | $310.6M | ||
| Q4 24 | $309.9M | $302.0M | ||
| Q3 24 | $315.1M | $295.9M | ||
| Q2 24 | $339.8M | $284.3M |
净利润CCRNPCOR
| Q1 26 | — | $-9.1M | ||
| Q4 25 | $-82.9M | $-37.6M | ||
| Q3 25 | $-4.8M | $-9.1M | ||
| Q2 25 | $-6.7M | $-21.1M | ||
| Q1 25 | $-490.0K | $-33.0M | ||
| Q4 24 | $-3.8M | $-62.3M | ||
| Q3 24 | $2.6M | $-26.4M | ||
| Q2 24 | $-16.1M | $-6.3M |
毛利率CCRNPCOR
| Q1 26 | — | 80.1% | ||
| Q4 25 | — | 80.1% | ||
| Q3 25 | 20.4% | 79.7% | ||
| Q2 25 | 20.4% | 79.1% | ||
| Q1 25 | 20.0% | 79.1% | ||
| Q4 24 | — | 81.2% | ||
| Q3 24 | 20.4% | 81.4% | ||
| Q2 24 | 20.8% | 83.1% |
营业利润率CCRNPCOR
| Q1 26 | — | 15.5% | ||
| Q4 25 | -30.2% | -12.3% | ||
| Q3 25 | -2.4% | -4.4% | ||
| Q2 25 | -2.1% | -9.3% | ||
| Q1 25 | -0.3% | -11.7% | ||
| Q4 24 | -1.1% | -21.9% | ||
| Q3 24 | 0.9% | -12.3% | ||
| Q2 24 | -5.7% | -5.2% |
净利率CCRNPCOR
| Q1 26 | — | -2.5% | ||
| Q4 25 | -35.0% | -10.8% | ||
| Q3 25 | -1.9% | -2.7% | ||
| Q2 25 | -2.4% | -6.5% | ||
| Q1 25 | -0.2% | -10.6% | ||
| Q4 24 | -1.2% | -20.6% | ||
| Q3 24 | 0.8% | -8.9% | ||
| Q2 24 | -4.7% | -2.2% |
每股收益（稀释后）CCRNPCOR
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $-2.56 | $-0.25 | ||
| Q3 25 | $-0.15 | $-0.06 | ||
| Q2 25 | $-0.20 | $-0.14 | ||
| Q1 25 | $-0.02 | $-0.22 | ||
| Q4 24 | $-0.13 | $-0.42 | ||
| Q3 24 | $0.08 | $-0.18 | ||
| Q2 24 | $-0.47 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $386.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $1.2B |
| 总资产 | $449.0M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNPCOR
| Q1 26 | — | $386.0M | ||
| Q4 25 | $108.7M | $768.5M | ||
| Q3 25 | $99.1M | $684.0M | ||
| Q2 25 | $81.2M | $620.9M | ||
| Q1 25 | $80.7M | $566.7M | ||
| Q4 24 | $81.6M | $775.4M | ||
| Q3 24 | $64.0M | $756.9M | ||
| Q2 24 | $69.6M | $735.4M |
股东权益CCRNPCOR
| Q1 26 | — | $1.2B | ||
| Q4 25 | $322.8M | $1.3B | ||
| Q3 25 | $408.1M | $1.2B | ||
| Q2 25 | $412.2M | $1.2B | ||
| Q1 25 | $418.2M | $1.2B | ||
| Q4 24 | $419.0M | $1.3B | ||
| Q3 24 | $424.7M | $1.3B | ||
| Q2 24 | $433.3M | $1.3B |
总资产CCRNPCOR
| Q1 26 | — | $2.1B | ||
| Q4 25 | $449.0M | $2.2B | ||
| Q3 25 | $538.2M | $2.1B | ||
| Q2 25 | $553.8M | $2.0B | ||
| Q1 25 | $576.2M | $1.9B | ||
| Q4 24 | $589.3M | $2.1B | ||
| Q3 24 | $597.4M | $2.0B | ||
| Q2 24 | $602.9M | $2.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $76.8M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | — |
| 自由现金流率自由现金流/营收 | 6.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势，按日历期对齐
经营现金流CCRNPCOR
| Q1 26 | — | $76.8M | ||
| Q4 25 | $18.2M | $114.9M | ||
| Q3 25 | $20.1M | $88.5M | ||
| Q2 25 | $4.2M | $30.8M | ||
| Q1 25 | $5.7M | $66.0M | ||
| Q4 24 | $24.2M | $29.1M | ||
| Q3 24 | $7.5M | $39.3M | ||
| Q2 24 | $82.4M | $58.7M |
自由现金流CCRNPCOR
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $109.2M | ||
| Q3 25 | $17.9M | $83.1M | ||
| Q2 25 | $2.3M | $27.9M | ||
| Q1 25 | $3.8M | $62.0M | ||
| Q4 24 | $21.7M | $17.4M | ||
| Q3 24 | $6.3M | $35.7M | ||
| Q2 24 | $79.6M | $56.8M |
自由现金流率CCRNPCOR
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 31.3% | ||
| Q3 25 | 7.2% | 24.5% | ||
| Q2 25 | 0.8% | 8.6% | ||
| Q1 25 | 1.3% | 20.0% | ||
| Q4 24 | 7.0% | 5.8% | ||
| Q3 24 | 2.0% | 12.1% | ||
| Q2 24 | 23.4% | 20.0% |
资本支出强度CCRNPCOR
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 1.6% | ||
| Q3 25 | 0.9% | 1.6% | ||
| Q2 25 | 0.7% | 0.9% | ||
| Q1 25 | 0.6% | 1.3% | ||
| Q4 24 | 0.8% | 3.9% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.8% | 0.7% |
现金转化率CCRNPCOR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
PCOR
暂无分部数据
